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Cervical cancer remains a common malignancy in women. Lymph node is one of the signiﬁcant
important prognostic factors. Until now, there is no reliable investigative study that can evaluate nodal
status the same as the International Federation of Gynecology and Obstetrics (FIGO) clinical staging
system. Radical hysterectomy and pelvic lymphadenectomy is still one option in the standard treatment
of patients with early-stage cervical cancer that can reveal metastatic lymph node but which can also
produce treatment-related morbidities and complications. Sentinel lymph node identiﬁcation has
become a valuable technique for nodal status assessment. If lymph node metastasis was identiﬁed early,
then unnecessary invasive surgical operations and complications may be avoided.
Copyright  2012, The Asia-Paciﬁc Association for Gynecologic Endoscopy and Minimally Invasive
Therapy. Published by Elsevier Taiwan LLC. All rights reserved.Introduction
The third most common female malignancy is cervical cancer;
530,000 new cases were diagnosed in 20081 and 250,000 deaths
from it occurred in 2005, approximately 80% of deaths happened
in developing countries.2 Cervical cancer is still the ﬁfth leading
cause of cancer death (9.1 per 100,000) of women in Taiwan.3
Nodal status is the most signiﬁcant negative prognostic factor of
cervical cancer and may also reveal the lymphatic spreading.4
Likely as radical hysterectomy accompanied with pelvic lympha-
denectomy still have the role in early stage cervical cancer treat-
ment. If the risk factors of the lymphatic metastasis were
identiﬁed, surgery may be skipped to another appropriate
modality primarily.5 Even though signiﬁcant morbidity possibly
occurred if extensive surgical procedures were performed.
According to operative disadvantages, many studies were pro-
gressed for decreasing those adverse effects.
Basis of sentinel lymph node detection
Sentinel lymph node (SLN) was deﬁned as the ﬁrst node in
regional lymphatic basin that receives primary lymphatic
drainage.6,7 If SLN does not emerge, the remaining regional nodesnd Gynecology, Chang Gung
g Gung University College of
, Taiwan.
uang).
ia-PaciﬁcAssociation forGynecologicEnshould also be free of metastases. Thus SLN identiﬁcation was an
alternative resource for avoiding unnecessary lymphadenectomy
and surgical interventions. The SLN concept is not only generated
from many studies for nongynecologic tumors, such as penile
cancer,8 breast cancer,9 and melanoma,10,11 but it was also utilized
for gynecologic malignancy treatment12,13 thereafter. Nowadays,
the practical lymphatic mapping methods use vital blue dye and
lymphoscintigraphy techniques.6,7,14 The modes for SLN identiﬁ-
cation are labeled as “hot” and/or “blue” as shown in Fig. 1. Types of
materials and trial proceedings were selected dissimilarly.
Materials used for detecting SLN
There are various reporting methods for SLN detection, e.g., vital
blue dye and radioactive isotopes in single or a combined tech-
nique.6,15 The three most commonly used vital dyes are isosulfan
blue, patent blue violet, and methylene blue by injection intrader-
mally 5e10 mm in depth around the primary cervical tumor,
avoiding tumoral or intravascular infusion directly to avoidance of
high background signal intensity that can decline SLN detection
rate. The radioactive materials that are preferably used in different
countries always contain Technetium-compounds. The efﬁciency of
most trials was reported similarly in that the combined vital blue
dye and isotope material technique had a detection rate of more
than 80% to nearly 100% 16e30 and appears to be superior to lym-
phoscintigraphy 16,21,28,31,32 or vital dye technique alone.16,21,28,33,34
However, there are many studies that display satisfactory results
from noncombined methods.35e40doscopyandMinimally InvasiveTherapy.PublishedbyElsevierTaiwanLLC.All rightsreserved.
Fig. 1. The arrow indicates the positive blue stained node.
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Many authors exhibit that combined technique had more than
90% and up to 100% of detection rate.17e22,24e29 Malur S et al16 re-
ported 100% sensitivity rate with no false-negative result in
combined Technetium 99 m (99mTc)-radiolabeled albumin (patent
blue technique) group, while a 16.6% false negative result was
found in the blue dye group. This is similar to Niikura et al23 and
Plante et al,19 whose success consisted of a 93% detection rate, a 93%
sensitivity, and a 0% false negative rate. Rhim et al18 enrolled 26
patients with early stage cervical carcinoma into a study and
reported a 94% SLN detection rate with a 4.76% false negative rate,
while O’Boyle and associates33 found 20% (4/20 patients) micro-
scopic nodal metastasis using the blue dye technique. However,
Lelievre et al41 found only a 71.4% detection rate using the
combined method. Their lymphoscintigraphy trial found that
two patients had one hot spot in the presacral node. Meanwhile,
the authors noted that these nodes may not be the ﬁrst
sentinel node and there was not enough radioactive value to
uncover. The combined technique demonstrated signiﬁcant high
SLN detection. 17,21 Altgassen C et al42 study in all stages of 590
invasive cervical cancer patients, 77.4% overall sensitivity was re-
ported. This series had variances in sample size between different
disease severity; thus, the severity of disease allocationmight affect
the low sensitivity as well.
Single technique in SLN detection
Van Dam et al31 studied intraoperative 99mTc-labeled nano-
colloid lymphatic mapping in 25 patients with cervical cancer and
found an 84% SLN identiﬁcation rate (21/25 patients). Angioli
et al32 reported a 89% detection rate by lymphoscintigraphy in 33/
35 cervical cancer patients, and there are some reports that show
a higher detection rate nearly or equal to 100%.35,36 Malur et al16
reported a detection rate of 76.2% in radiolabeled albumin but
55.5% in the blue dye group with 50% sensitivity. O’Boyle et al33
studies isosulphan blue dye and identiﬁed SLN in 20 patients
with early stage cervical carcinoma, reporting a 60% detection rate
and 50% sensitivity. They suspected their technical method was
insufﬁcient and this might be the cause of the restricted dye
uptake by tissue or lymphatic network cannot be exposed by
operative procedure favorably. The same result was found by
Seong et al,34 they stated that SLN detection failure in patientsmore than 50 years old may be inﬂuenced by the aging process.
With respect to anaphylactic reaction, a low dose of vital dye was
used in their trial; thus, the SLN detection rate may have been
affected. Nevertheless, these were good results in the different
trials. Di Stefano et al38 and Yuan et al40 studied methylene blue in
SLN identiﬁcation for patients with cervical cancer using lapa-
rotomy approach for radical hysterectomy and pelvic lymphade-
nectomy, their results also had high SLN identiﬁcation rate of 90%
and 93.9%.
Effect of process and materials in SLN detection
Each study has different manageable processes of investigating
materials as well as dissimilar results. Levenback et al17 studied
1.0e1.5 ml of ﬁltered technetium-99 radiocolloid for preoperative
lymphoscintigraphy. A total of 23 patients were injected into the
cervix before the day of operation; 16 patients were operated on
the day of the surgery. Isosulphan blue dye 3e4 ml was chosen
and performed after induction of general anesthesia on the day of
surgery for intraoperative lymphatic mapping. They found at least
one sentinel node detected on lymphoscintigraphy in 33 patients
(85%) and identiﬁed bilateral SLN in 21 patients, but there were no
localized SLN on lymphoscintigraphy in six patients. They did,
however, ﬁnd intraoperative bilateral hot lymph nodes instead,
and a gamma probe also detected hot SLN in all 39 patients.
Lymph nodes were detected after applied isosulphan blue dye
a median time of 7 minutes, and they remained blue for 21
minutes. At least one SLN was founded in each of the 39 patients
also. Rhim et al18 injected Technetium-99 m colloid albumin to the
patients 3 hours before surgery and isosulphan blue dye injection
after anesthesia. Identiﬁed SLN were located in external iliac,
obturator, and internal iliac sites sequentially. Niikura et al23
utilized 99mTc-labeled phytate radioisotope; because phytate
has a larger particle size than sulfur colloid or colloid albumin,
they suspected that it may extended in sentinel nodes and
declined the missing SLN as well as Rob L et al26 who used 99mTc-
labeled colloidal albumin with more than 80% particles of 100 to
600 nm in diameter. Several authors also considered that many
factors may affect the study, the volume of different materials,17 or
different half life in each substance.17 Some undetected SLN on
preoperative lymphoscintigraphy become hot node detected by
intraoperative radioactive counter. They explained that primary
tumor site,17,18 scanned timing before SLN can uptake radioactive
matters,17different infusion areas,17 or size of investigating mate-
rials23,26 may inﬂuence the results. Dargent et al37 studied
35 patients with laparoscopic surgery. Varying doses of patent
blue violet (PBV) were managed, then dye was injected at fornices
in 16 cases and 53 into the cervix. They revealed not only the
failure of SLN detection was 50%, 17%, and 8% after using PBV doses
of 1.5 ml, 2.0 to 3.9 ml and 4.0 ml respectively but also happening
for the site of injection (25% in fornices and 10% in cervix). The
blue-stained lymph nodes could be found after dye injection
between 20e150 minutes (25 minutes of median time) later. The
resembling results in Yuan and companions’ study40 suggested
that the SLN detection rate was higher in the group given 4 ml
methylene blue and accomplished to detect the blue nodes at least
120 minutes after dye injection in all 26 cases. Kushner DM et al43
evaluated SLN detection with a combined radiocolloid and dye
method in cervical cancer patients. They visualized the blue node
stable in 30 minutes and never seen after 50 minutes as well as Di
Stefano et al never displayed the SLN before 20 minutes and after
70 minutes of blue dye injection.38 The authors concluded that the
blue dye dosage and site of injection, the time between dye
injection and the operative procedure, may be factors that affected
the detection of SLN. By contrast, Altgassen and partners39
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patent blue. A high overall SLN detection rate was reported. The
dilutional blue dye pattern also demonstrated signiﬁcant sentinel
node detection in the parametrial region (37.0% vs. 10.3%). In
addition, Lelievre et al41 remarked that the proper amount of dye
material should be dictated because they experienced a trouble-
some tissue dissection when injecting nondiluted blue dye for
sentinel node detection. Buist et al20 suggested an observable
point that there is sometimes difﬁcult to ﬁnd the true SLN because
the blue dye had rapid absorbing time to lymphatic pathway, the
proper dye quantity should be considered. Regarding radioisotope
observation, maybe it is not clear-cut when separating groups of
lymph nodes. All of the detected nodes should be inspected.20
Nevertheless, this review article was focused on the traditional
method of sentinel node detection in cervical cancer. There are
limitations to the traditional method, including laparotomy and
laparoscopy approaches, that were found in our review. Therefore,
new research should be encouraged, including the near-infrared
(NTR) mapping of sentinel lymph nodes, which has been previ-
ously suggested.
Laparotomy and laparoscopy surgical approaches
Concerning surgical techniques, laparoscopy manner appears to
be a technique as feasible as laparotomy method in SLN identiﬁ-
cation procedures. A study of 50 cervical cancer cases of Malur
et al16 showed that SLN identiﬁcation rate with laparoscopy
method (76%) is similar in patients who received laparotomy
operation (80%). Buist et al20 study used laparoscopic procedure for
lymph node dissection and radical hysterectomy. They reported
that the laparoscopic method was achievable in SLN node dissec-
tion but they had to face a laparoscopic complication of vascular
injury and infected lymphocyst in three of the 24 patients (12.5%).
Plante and associates19 performed laparoscopically radical proce-
dures for 70 patients with early stage cervical carcinoma. The many
beneﬁts, bloodless, promote the magniﬁcation of intended opera-
tive area were described and needless maneuver can be ceased
when there is indicated. Similarly, Gil-Moreno et al25 performed
laparoscopic SLN identiﬁcation and radical hysterectomy in 12
patients. There was good outcome and 100% detection rate, so the
laparotomy procedure was not applied and no serious complica-
tions were found. The same results occurred during the study of
Díaz-Feijoo et al.44 They noted success in SLN identiﬁcation when
they used the laparoscopic approach method, including shorter
hospitalization, and lower blood loss than a laparotomy procedure.
The overall survival and disease free survival were also similar
between the two groups. However, it should not be ignored that
physician skills and appropriate equipment are important for good
surgery and preventing potential complications from laparoscopic
procedure.
Conization affecting SLN detection
Several studies mentioned that the demographic data of
patients does not seem to be related to factors of the SLN identiﬁ-
cation test, as well as the fact that preoperative conization was not
affected by the possibility of SLN identiﬁcation.17,37 Perhaps Seong
and companions34 perceived that SLN was detected higher in pre-
perative conization (73.3% vs. 49.1%), but all of these patients
were older than 50 years. Thus, perhaps they presumed that the
patients’ ages may be tied to sentinel node detection. A similar
result was suggested by Coutant et al,45 who said that the false
negative rates in previous conization compared with without
preoperative conization were 33.5% and 8.3%, respectively. They
explained that the blue dye injection might have passed throughthe post conized cervical tissue and lymphatic drainage system
might be altered in the post conized cervical tissue already.
Cervical tumor size affects SLN detection
Rob et al26 selected combined techniques for SLN detection in
183 early stage cervical malignant cases with different tumor sizes.
They noticed that the SLN detection rate in patients with tumors
<2.0 cm in diameter in both of the laparoscopy and laparotomy
groups were 90.48% and 91.67%, respectively; furthermore, the
detection rate of patients with tumor sizes>2.0 cmwas 80% and, in
patients with bulky tumors who received neoadjuvant chemo-
therapy, the researchers found that this group had the lowest
detection rate (60%), adding that one patient had one positive
presacral nodewhen sentinel nodes were not detected. This ﬁnding
was similar to the study of Fader and coworkers29 who discovered
there was a 100% SLN detection rate when tumor size was <2.0 cm.
Even if one patient, who experienced of stage IB1 had a 3-cm
cervical tumor mass, had been missed SLN detection on lympho-
scintigraphy technique. The similar result was found in the O’Boyle
et al33 study, which elucidated that 73% (11/15 patients) of sentinel
node detection in tumor size4.0 cm and 20% (one of ﬁve patients)
in tumors >4.0 cm in diameter. They noticed that the larger volu-
metric tumor may disturb lymphatic channel drainage, decreasing
SLN identiﬁcation rate29,33 and skipping node metastasis29 can be
occurred. Other similar studies were reported the same. Barranger
and colleagues46 revealed the lower detection rate of SLN with
a 20% false negative rate in locally advanced cervical cancer patients
in the ﬁrst laparoscopic SLN detection report, but they found no
false negative rate in early cervical cancer stages. Silva LB et al35
expressed that the SLN identiﬁcation rate was less than 40% in
advanced cervical cancer stages, which was the same as Altgassen
and associates42 who revealed a 94% sentinel node detection rate in
tumor mass size 2.0 cm or less which has higher than tumor size
more than 2.0 in diameter (83.6%) signiﬁcantly. However, Daraï E
et al30 found that two staged IIB patients hadmetastasis negative in
SLN and positive in non-SLN; furthermore, nine cases without
parametrial involvement were found in two patients (22.2%).
However, they accepted that the parametrial invasion were asso-
ciated with lymphatic spreading factors, tumor size, or advanced
disease. Thus, the authors in this study did not agree that SLN
methods could support pelvic node status evaluation as well.
Conclusion
Nowadays, many gynecologic oncologists make efforts to ﬁnd
valuable strategies that can reducemorbidity and increase accuracy
in cervical cancer treatment. Thus, lymphatic mapping with
sentinel node detection by vital dye and radioisotope materials
became an important role in management of cervical cancer. Many
factors, including cervical tumor size, detection materials, surgical
methods, and physician experience, are related to sentinel node
identiﬁcation in cervical cancer. More research should be encour-
aged to improve and standardize cervical cancer sentinel node
detection in clinical applications.
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